Inactive Instrument

Highlights DanDrit Biotech USA Inc OTC Bulletin Board

Equities

US2360781015

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

05-24	Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	MT
05-24	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	05-24	MT
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	05-24	CI
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-15	CI
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	04-24	MT
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-14	CI
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	02-13	MT
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg	02-13	MT
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd. for $59.2 million.	02-12	CI
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube	01-25	MT
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	02/10/23	CI
Renovaro Biosciences, GEDi Cube Enter Stock-for-stock Acquisition Deal	29/09/23	MT
Renovaro BioSciences Signs Letter of Intent to Merge With GEDi Cube; Shares Rise	09/08/23	MT
Renovaro Biosciences Inc. signed a letter-of-intent to acquire GEDi Cube Intl Ltd.	08/08/23	CI
Enochian Biosciences Inc. Announces That Its Cancer Platform Remains on Track for Trials in Humans Following FDA Review	08/06/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	12/05/23	CI
Enochian Biosciences Inc. Announces Scientific Presentation of Proof-of-Concept Studies for Potential Therapy for Cancers with a Poor Life Expectancy	29/03/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	09/03/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	07/03/23	CI
Enochian Biosciences, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	27/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DanDrit Biotech USA Inc OTC Bulletin Board

Equities

US2360781015

Highlights

Filters